NCI-H1650

Export PDF

Strain Information

Cell Line

NCI-H1650

Cat. NO.

NM-F09

Model Description

NCI-H1650 is a cell line exhibiting epithelial morphology that was isolated in 1987 from the lung tissue of a 27-year-old, male smoker with stage 3B, bronchoalveolar carcinoma.

Strain State

Validation of tumorigenic capacity completed

Validation Data

I. Characterization of in vivo growth kinetics

The NCI-H1650 cells were subcutaneously inoculated into the M-NSG mice.

image.png

Figure 1. Tumor growth curve of NCI-H1650 xenograft model (n=12)

image.png


Figure 2. Body weight change of NCI-H1650 xenograft model (n=12)

Survival-4.jpg

Figure 3. Survival curve of NCI-H1650 xenograft model (n=12)

*Wild-type cell lines are not for sale, and only applied to construction of tumor bearing mice and in-vivo efficacy studies.

Related Strain(s)

You may also like

Shanghai Model Organisms Center Inc has licensed CRISPR-Cas9 technology from Broad Institute

On Dec 16, 2018, Broad Institute and Shanghai Model Organisms Center Inc (SMOC) has entered into a non-exclusive license agreement under which Broad has granted SMOC worldwide rights to commercialize a service platform for genetically modified mouse models under Broad's intellectual property.

Learn more
Customizing Mouse Models: Delivering in 100 Days to Speed Up Your Research!

At GenoBioTX, we understand that the lengthy wait times for gene-modified mouse models can hinder your research progress. Traditional methods often require 6-9 months, leading to delays and increased costs. That’s why we’re thrilled to introduce our innovative service designed to streamline this process and deliver results faster.

Learn more